Birdwatch Note
2024-12-18 03:50:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The authors stated, "COVID-19 vaccines are recommended to reduce severe illness. The major limitation of this study was lack of sample size which precluded us from estimating vaccine effectiveness" https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piae121/7917119?login=false
Written by 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1869181746547225064
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1869228786425774084
- noteId - 1869228786425774084
- participantId -
- noteAuthorParticipantId - 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
- createdAtMillis - 1734493845933
- tweetId - 1869181746547225064
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The authors stated, "COVID-19 vaccines are recommended to reduce severe illness. The major limitation of this study was lack of sample size which precluded us from estimating vaccine effectiveness" https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piae121/7917119?login=false
Note Ratings
rated at | rated by | |
2024-12-18 18:39:15 -0600 | Rating Details | |
2024-12-18 10:26:52 -0600 | Rating Details | |
2024-12-18 09:19:17 -0600 | Rating Details | |
2024-12-18 09:15:41 -0600 | Rating Details | |
2024-12-18 08:44:22 -0600 | Rating Details | |
2024-12-18 08:34:45 -0600 | Rating Details | |
2024-12-18 08:20:31 -0600 | Rating Details | |
2024-12-18 08:20:15 -0600 | Rating Details | |
2024-12-18 07:49:30 -0600 | Rating Details | |
2024-12-18 07:20:54 -0600 | Rating Details | |
2024-12-18 06:02:42 -0600 | Rating Details | |
2024-12-18 04:51:44 -0600 | Rating Details | |
2024-12-18 04:28:40 -0600 | Rating Details | |
2024-12-18 02:59:23 -0600 | Rating Details | |
2024-12-18 02:44:58 -0600 | Rating Details | |
2024-12-18 02:39:02 -0600 | Rating Details | |
2024-12-18 02:14:03 -0600 | Rating Details | |
2024-12-18 01:50:12 -0600 | Rating Details | |
2024-12-18 01:49:47 -0600 | Rating Details | |
2024-12-18 01:43:43 -0600 | Rating Details | |
2024-12-18 01:33:45 -0600 | Rating Details | |
2024-12-18 00:36:20 -0600 | Rating Details | |
2024-12-18 00:22:51 -0600 | Rating Details | |
2024-12-18 00:06:39 -0600 | Rating Details | |
2024-12-17 23:53:15 -0600 | Rating Details | |
2024-12-17 23:16:59 -0600 | Rating Details | |
2024-12-17 23:14:50 -0600 | Rating Details | |
2024-12-17 23:00:46 -0600 | Rating Details | |
2024-12-17 22:58:51 -0600 | Rating Details | |
2024-12-17 22:56:20 -0600 | Rating Details | |
2024-12-17 22:53:07 -0600 | Rating Details | |
2024-12-17 22:23:58 -0600 | Rating Details | |
2024-12-17 22:20:05 -0600 | Rating Details | |
2024-12-17 22:08:36 -0600 | Rating Details | |
2024-12-17 21:56:44 -0600 | Rating Details | |
2024-12-20 07:53:59 -0600 | Rating Details | |
2024-12-19 21:37:22 -0600 | Rating Details | |
2024-12-19 02:40:10 -0600 | Rating Details | |
2024-12-18 20:27:29 -0600 | Rating Details | |
2024-12-18 15:09:04 -0600 | Rating Details | |
2024-12-18 09:47:04 -0600 | Rating Details | |
2024-12-18 08:17:27 -0600 | Rating Details | |
2024-12-18 06:52:00 -0600 | Rating Details | |
2024-12-18 02:32:34 -0600 | Rating Details | |
2024-12-18 01:54:37 -0600 | Rating Details | |
2024-12-18 01:11:12 -0600 | Rating Details | |
2024-12-18 00:18:54 -0600 | Rating Details | |
2024-12-18 00:05:41 -0600 | Rating Details | |
2024-12-17 23:45:29 -0600 | Rating Details | |
2024-12-17 23:24:44 -0600 | Rating Details | |
2024-12-17 23:19:22 -0600 | Rating Details | |
2024-12-17 23:14:19 -0600 | Rating Details | |
2024-12-17 22:31:48 -0600 | Rating Details | |
2024-12-17 22:07:43 -0600 | Rating Details | |
2024-12-17 21:59:06 -0600 | Rating Details | |
2024-12-17 21:52:32 -0600 | Rating Details | |
2024-12-18 17:43:49 -0600 | Rating Details | |
2024-12-18 10:17:44 -0600 | Rating Details | |
2024-12-18 02:38:23 -0600 | Rating Details | |
2024-12-18 00:27:23 -0600 | Rating Details | |
2024-12-18 00:14:41 -0600 | Rating Details | |
2024-12-18 00:11:03 -0600 | Rating Details | |
2024-12-18 00:05:29 -0600 | Rating Details | |
2024-12-17 23:58:20 -0600 | Rating Details | |
2024-12-17 23:55:21 -0600 | Rating Details | |
2024-12-17 22:24:13 -0600 | Rating Details |